INS and Hyperglycemia: In HFD-induced diabetic rats, the intraperitoneal administration of RA (200 mg/kg/day for 28 days) dose-dependently ameliorated hyperglycemia and increased insulin sensitivity assessed by the oral glucose tolerance test (OGTT).